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INTRODUCTION
With the widespread availability of imaging tech-
niques, focal fatty change of the liver (FFC) has
become a well-recognized radiological entity (1-5).
However, this entity may cause significant difficulties
in the differential diagnosis of a focal hepatic lesion
i.e. misdiagnosis of an FFC area as malignancy and
vice versa (1-8). In this paper, we report a case of focal
fatty change in the liver, which was suspected of
being malignant.
CASE REPORT
A 53-year-old woman with poorly controlled diabetes
mellitus, was referred from another institution due to
ultrasonographic findings of multiple hyperechogenic
masses in the liver. The patient complained of right
upper abdominal pain of one year’s duration. Physical
examination revealed obesity, tender hepatomegaly
and pain in the right upper abdominal quadrant
upon deep palpation. Her blood urea, creatinine,
aspartate aminotranferase, alanine aminotransferase,
alkaline phosphatase, gamma-glutamyl transpeptidase
and alpha-fetoprotein levels were normal. Serology for
hepatitis B and C viruses were negative. The patient
had no history of alcohol consumption. Complete
blood count and electrophoresis of serum proteins
were normal. The available computerized tomogra-
phy (CT) images (November 1995) revealed well
circumscribed hypodense lesions in the left lobe
(21 mm), the caudate lobe (50 mm) and the right
lobe (17mm) (Figure 1a-1b). All lesions were similar
in appearance. The average attenuation value of
-37 Hounsfield units (HU) was compatible with the
fatty nature of these lesions. A control magnetic
resonance imaging (MRI) study was performed
(February 1996). The lesions in the left and right
lobes were no longer visible ; the large lesion in the
caudate lobe had regressed considerably and there
was a new lesion on the anterior surface of the left
lobe (Figure 2). The fatty nature of these lesions
was confirmed by fat-saturation sequences (Figure 3).
Thru-cut biopsy of the caudate lobe lesion was
performed under CT-guidance (Picture 1). Biopsy
revealed septal fibrosis with moderate macro- and
microvesicular steatosis. The patient had poorly con-
trolled diabetes mellitus. Her diabetes was regulated
with insulin and diet and she was discharged with
the diagnosis of FFC. On follow-up examination ten
months later, she had no obvious complaints. Com-
puterized tomography was performed (December
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1996). The lesion in the caudate lobe had disappeared
while the lesion in the left lobe had increased in size ;
there was a new lesion in the right lobe (Figure 4).
FNB from the left lobe lesion again revealed steatosis.
On MRI examination performed in January 1997,
all lesions had regressed. On MRI scan in May 1997,
all lesions had disappeared (Figure 5).
Fig. 2. MRI scan of the patient (February 1996) : There was a
new lesion in the left lobe (top arrow). The caudate lobe lesion
had decreased in size (bottom arrow) ; the other lesions had
disappeared.
Fig. 3. MRI fat-saturation sequence of the image in Figure 2
(February 1996)
Fig.5. Final MRI image (May 1997) : all lesions had disappeared.
Fig.4. Control CT image (December 1996) : showing the left
lobe lesion extending to the anterior surface of the right lobe.
The caudate lobe lesion had disappeared.
Fig.1a. The initial CT of the patient (November 1995) with IV
contrast, showing lesions in the right and caudate lobes of the
liver.
Fig.1b. Arrow indicates the lesion in the left lobe of the liver.
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DISCUSSION
Focal fatty change in the liver, which is a benign
lesion, may pose important diagnostic difficulties.
Various clinical and radiological criteria have been
proposed for differentiating these lesions from liver
neoplasms : 1〕The history and clinical examination
of the patient may reveal factors implicated in fatty
change, such as alcohol consumption, diabetes and
obesity (4). These factors are, of course, suggestive
but not diagnostic. 2〕Focal fatty change occursmore
frequently in the periligamentous and periportal
regions (5). However, any part of the liver may be
involved (4) as observed in our patient. 3〕Focal
fatty change usually does not exert any mass effect
on the surrounding normal parenchyma or the blood
vessels passing through the area (5) but exceptions
have been reported (6). More importantly, the absence
of mass effect in some malignant neoplasms has
been documented (7). 4〕CT attenuation value can
suggest the fatty nature of the lesion ; for example,
the value af -37 HU in our patient was correctly
considered compatible with fatty change. However,
the overlap with malignant tumors is not insignificant
and‘typical’values may be found in the absence of
steatosis. For example, Leifer et al. reported a case
of ovarian carcinoma metastatic to the liver. In that
case, the lesion met the‘absence of mass effect’
and CT attenuation criteria, but turned out to be a
metastasis ; the diagnosis was finally made on biopsy
which revealed little fat content (8). 5〕MRI may
be used for reliable detection of tissue fat (5).
Unfortunately, accurate detection of fat does not rule
out malignancy, only limits the extent of differen-
tial diagnosis. It is a well-known fact
hepatocellular carcinoma, the most com-
mon primary malignancy of the liver may
contain fat (10, 11) ; other fat-containing
lesions include angiomyolipoma, myelo-
lipoma, adenoma, liposarcoma andmetas-
tatic teratomatous liver implants (9). 6〕
Another property of focal fatty change is
reversibility i.e. these lesions may resolve
over time. The mechanism of this reso-
lution is unclear. Sawada et al. suggested
that the regression of the lesion in their
two cases were related to metabolic con-
trol (2). In contrast, Clain et al. reported
two diabetic patients with focal fatty
change that showed‘changing appear-
ances over time’(12) and reported that
the changes in the liver were unrelated
to the improvement in diabetic control. In our patient,
it is difficult to ascribe the changes to better diabetic
control since some lesions had already started to
regress when she was admitted to our clinic while
new ones had started to appear. After the patient
came under our supervision, her blood glucose profile
was much improved but this was not paralleled by
liver changes. Reversibility, although of academic
interest, has limited value in a clinical setting where
management decisions must be made.
To our knowledge, the discordant evolution of
individual FFC lesions in the same patient i.e. regres-
sion in one lesion with appearance or progression of
other lesions, has been reported in only one previous
case (12). These observations are important for
discussions on the etiology of FFC because a
‘purely metabolic’hypothesis can not account for
the discordance of these changes.
The diagnostic problem posed by FFC is not limited
to the misdiagnosis of a malignancy as FFC ; the
opposite is also possible. FFC may mimic metastatic
disease (13-15), cause errors in the evaluation of
response to therapy (15) and lead to mismanagement
(13, 15). For example, Lilenbaum et al. reported a
renal cell carcinoma patient who developed FFC
(initially diagnosed as a liver metastasis) during the
course of interleukin-2 treatment. The authors warn
that‘Potential misdiagnosis of these lesions may
lead to premature discontinuation of IL-2 in patients
who might otherwise benefit from continuing treat-
ment’(15).
Fine needle biopsy (FNB) has proved to be an
effective tool in establishing the diagnosis (14-16).
Caturelli et al. reported the most extensive experi-
Picture 1. Thru-cut biopsy picture showing macrovesicular steatosis (30%) and
moderate septal fibrosis (Masson trichome x 125).
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ence. In 17 patients (7 had previous malignancies),
the possibility of FFC was considered based on
ultrasonographic findings and the diagnosis was
made with FNB. Follow-up confirmed the evaluation
in every case.
In conclusion, the diagnosis of focal fatty change
can be strongly suggested by clinical, biochemical
and radiologic criteria. However, an exact diagnosis
can only be made with fine needle biopsy. This should
be performed without hesitation in all patients in
whom a change in treatment based on histopathology
is possible.
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